165 related articles for article (PubMed ID: 36412398)
1. The immunohistochemical biomarker B-cell lymphoma-2 expression in malignant and premalignant lesions of the uterine cervix and its association with human papillomavirus infection.
Nayak PK; Hussain N; Negi S; Agrawal S; Bagde N; Mitra S; Singh V
J Cancer Res Ther; 2022; 18(6):1485-1489. PubMed ID: 36412398
[TBL] [Abstract][Full Text] [Related]
2. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia.
Cooper K; Haffajee Z; Taylor L
Mod Pathol; 1999 Jun; 12(6):612-7. PubMed ID: 10392638
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
4. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix.
Saegusa M; Takano Y; Hashimura M; Shoji Y; Okayasu I
Cancer; 1995 Dec; 76(11):2297-303. PubMed ID: 8635035
[TBL] [Abstract][Full Text] [Related]
5. [Human papillomavirus associated cervix uteri morbidity in Hungary: epidemiology and correlation with the HPV types and the simultaneous cytological diagnosis].
Szentirmay Z; Veleczki Z; Kásler M
Orv Hetil; 2017 Aug; 158(31):1213-1221. PubMed ID: 28758434
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
[TBL] [Abstract][Full Text] [Related]
7. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16
Badiga S; Chambers MM; Huh W; Eltoum IA; Piyathilake CJ
Cancer; 2016 Dec; 122(23):3615-3623. PubMed ID: 27479745
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterine cervix.
Maehama T
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):77-80. PubMed ID: 16011997
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus 16 and 18 infection of the uterine cervix in women with different grades of cervical intraepithelial neoplasia (CIN).
Takac I; Marin J; Gorisek B
Int J Gynaecol Obstet; 1998 Jun; 61(3):269-73. PubMed ID: 9688488
[TBL] [Abstract][Full Text] [Related]
11. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytokeratin polypeptides in human papillomavirus (HPV) lesions of the uterine cervix: 1. Relationship to grade of CIN and HPV type.
Syrjänen S; Cintorino M; Armellini D; Del Vecchio MT; Leoncini P; Bugnoli M; Pallini V; Silvestri S; Tosi P; Mäntyjärvi R
Int J Gynecol Pathol; 1988; 7(1):23-38. PubMed ID: 2450850
[TBL] [Abstract][Full Text] [Related]
13. The application of human papilloma virus genotyping for the identification of neoplasm lesions in the cervix of women with abnormal cytology smears.
Ciszek B; Heimrath J; Ciszek M
Adv Clin Exp Med; 2012; 21(6):759-66. PubMed ID: 23457134
[TBL] [Abstract][Full Text] [Related]
14. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
15. Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
Acta Cytol; 2006; 50(1):6-15. PubMed ID: 16514834
[TBL] [Abstract][Full Text] [Related]
16. Endonuclease-resistant DNA: a novel histochemical marker for cervical intraepithelial neoplasia and cervical carcinoma.
Castellanos MR; Davidov A; Punia V; Szerszen A; Maiman M; Lazzaro B; Ahern K; Banerjee P
Int J Gynecol Pathol; 2012 Jan; 31(1):1-7. PubMed ID: 22123717
[TBL] [Abstract][Full Text] [Related]
17. Study on the Association between the Fibroblast Growth Factor Receptor 4 Expression and High-Risk Human Papillomavirus Infection in Cervical Cancer and Precancerous Lesions.
Guo L; Zhao A; Zhang R; Xie Y; Xu X
Gynecol Obstet Invest; 2018; 83(6):608-614. PubMed ID: 29982249
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the efficacy and safety of Nocardia rubra cell wall skeleton immunotherapy for cervical high-risk HPV persistent infection].
Chen F; Di W; Hu YJ; Li CZ; Wang F; Duan H; Liu J; Yao SZ; Zhang YZ; Guo RX; Wang JD; Wang JL; Zhang YQ; Wang M; Lin ZQ; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):536-545. PubMed ID: 37474327
[No Abstract] [Full Text] [Related]
19. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.
Munmany M; Marimon L; Cardona M; Nonell R; Juiz M; Astudillo R; Ordi J; Torné A; Del Pino M
BJOG; 2017 Feb; 124(3):495-502. PubMed ID: 27506510
[TBL] [Abstract][Full Text] [Related]
20. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
